GENE ONLINE|News &
Opinion
Blog

Pfizer
10 Top Gene Therapy Companies in 2021
2021-03-26
Pfizer Sells Manufacturing Facilities in China to WuXi Biologics
2021-03-18
Japan Kicks off COVID-19 Inoculations with Pfizer-BioNTech Vaccine
2021-02-19
Pfizer’s Panzyga Receives FDA Approval for Rare Neurological Disease
2021-02-17
COVID-19: Another Study Suggests Pfizer/BioNTech Vaccine is Capable of Neutralizing UK Variant
2021-01-20
FDA Greenlights Pfizer’s Xalkori for a Rare Form of Non-Hodgkin Lymphoma
2021-01-19
Key Takeaways from the JPM Healthcare Conference: Gilead, Regeneron Lay Oncology Plans, Merck Looks Beyond Keytruda
2021-01-17
GeneOnline’s Top 10 Headlines of the Year
2020-12-30
Putting the Bio in Canadian Biomanufacturing
2020-12-25
New COVID-19 Variant: Vaccine Makers Optimistic but Experts are Cautious over Unique Mutations
2020-12-24
Fosun to Import 100 Million Doses of BioNTech’s COVID-19 Vaccine into China
2020-12-17
Singapore Becomes First Country in Asia Pacific to Greenlight Pfizer/BioNTech’s COVID-19 Vaccine
2020-12-16
FDA Green Lights Very First COVID-19 Vaccine in the US
2020-12-12
Pfizer’s COVID Vaccine Inches Closer to Emergency Approval Following FDA Panel’s Recommendation
2020-12-11
R&D
Novartis’ Chronic Myeloid Leukemia Drug Demonstrates Superior Results to Pfizer’s
2020-12-10
1 4 5 6 7 8 9
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top